Participated · Series A · Jul 2026

Karoo Health builds an operating system for cardiovascular care that unifies clinical, claims, pharmacy and patient data to enable earlier risk detection and coordinated care. The company operates programs with national and regional health plans and supports a network of more than 600 cardiology providers across 11 states. In deployed programs, independent analyses reported reductions of more than 40% in emergency department visits and inpatient admissions and early results showing greater than a 10% reduction in total cost of care for attributed populations. Karoo plans to continue developing its AI-native platform—advancing predictive models and clinical signal detection—and to expand its engineering and clinical teams. The company will also scale deployments with payer and provider partners nationwide. Karoo announced the $16.2 million Series A in July 2026.

Led · Series A · Sep 2025

Vouched provides an AI-powered identity and agent verification platform, with its Know Your Agent (KYA) suite and KnowThat.ai Agent Reputation Directory for onboarding, monitoring, and compliance. The KYA suite includes modules for credentials, risk, and continuous compliance, and offers developer-friendly APIs plus a turnkey MCP-Identity server supporting the Model Context Protocol (MCP). Its platform enables real-time monitoring and anomalous-agent detection to help enterprises maintain transparent, secure, and compliant agent interactions. Vouched serves industries with critical verification needs—such as healthcare, finance, and automotive—and has traction in e-commerce, digital marketplaces, and regulated sectors. The company says it verifies millions of human and AI agent identities annually and is used by organizations around the world. With the new funding it plans to advance product development, expand industry partnerships, and scale the KYA platform. Vouched provides an AI-based identity verification platform that delivers multi-dimensional, dynamic verification of individuals. Its core product is used by regulated and commercial businesses to quickly and accurately verify individuals while minimizing fraud risk. The company serves more than 300 banks, fintechs and healthcare providers, including Alloy and Hims Health. Vouched intends to use the new funds to enhance its platform, recruit talent, and extend support for financial services and healthtech businesses. Founded in 2018 and led by John Baird, the company is based in Seattle, WA. To date the company has raised more than $18m. Vouched offers an AI and computer vision–driven, end-to-end visual identity verification service that performs real-time fraud detection across government-issued IDs. The platform is expert on more than 550 government-issued identity documents in 70+ countries and supports touchless verification. Vouched has verified nearly 3 million individuals worldwide and serves more than 150 companies across banking, fintech, healthcare, telemedicine, legal, travel/hotel, car rentals, ecommerce, art purchasing, wire transfers, and employment screening. The company emphasizes fast, rigorous, accurate, and compliant online verification to enable digital access to services like banking, healthcare, and government aid. Management says the business will accelerate growth and expand its worldwide identity platform through strategic partnerships, particularly with banking and legal services. Vouched positions its product as a competitive advantage for businesses migrating interactions online and expects continued enterprise adoption. Vouched builds proprietary artificial intelligence and computer-vision systems that power end-to-end visual identity verification and fraud detection in real time. The platform is an expert on more than 450 government-issued identity documents across 50+ countries and serves banks, fintechs, hospitals, e-commerce, and gig and sharing businesses. Vouched’s technology verifies identities in challenging, real-world image conditions and quickly learns new IDs, adapting to diverse business use cases. The company announced a $3M funding round to accelerate growth across banking, fintech, and healthcare verticals. Vouched intends to use the funding to expand into the European market to address PSD2 and new AML compliance demand. Bankers Healthcare Group will also help bring Vouched’s services to nearly 1,200 members of its BHG Bank Network and healthcare partners.

Participated · Seed · Feb 2025

Charta Health offers an AI-powered platform that performs automated pre-bill reviews to identify missed coding opportunities, prevent claim denials, and ensure compliance with billing standards. Its core features include automated pre-bill review, AI-powered denial prevention, and customizable compliance audits. The company positions its solution to help healthcare providers optimize revenue, reduce manual effort, and achieve 100% revenue integrity. Charta was founded by Justin Liu and Scott Morris, former engineers at Rockset (acquired by OpenAI). The company recently raised seed funding and plans to use the proceeds to expand R&D, grow the team, and further enhance its AI-driven platform.

Led · Equity · Feb 2025

Avandra operates a federated network and marketplace for de-identified medical images and clinical data, positioning itself as the world’s largest such network. Its core product is an imaging-centric data platform that indexes and makes multimodal last-mile data available to biopharma, researchers, providers, and AI companies. The company aims to crawl, index, and make available up to 1 trillion images and says over 90% of imaging data research requests go unfulfilled by existing solutions. Avandra plans to expand its data network through partnerships with leading health systems and integrate its platform into broader health-data ecosystems. The company recently formed a strategic partnership with Datavant to enable seamless, privacy-preserving integration into Datavant’s ecosystem. The announced funding will be used to further develop the platform and scale commercial initiatives with biopharma and medical researchers.

Participated · Series B · Jul 2023

Proclaim builds the Custom-Jet Oral Health System: a 3D-printed, personalized mouthpiece paired with a hydro station that pulses 60 jets of pressurized water over seven seconds. The system is intended to be used alongside regular brushing and is clinically claimed to be 10× more effective at reducing gum bleeding, nearly 13× more effective at reducing gum inflammation, and almost 8× more effective at reducing plaque versus daily brushing and string flossing. Each mouthpiece is customized to an individual’s anatomy to target plaque and bacteria precisely. Proclaim raised $15 million in a Series B to fund initial commercialization and scale awareness and education among dental professionals and consumers. CEO Heberto Calves said the round is meant to set the stage for a growth C round in Q3 2024. The company positions the product as an at-home oral-health platform that could also help address broader systemic health issues linked to gum disease.